Medexus Pharmaceuticals Inc. (MEDXF)

Medexus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	14.98	23.97	5.26	13.07	10.02	18.7
Cash & Short-Term Investments	14.98	23.97	5.26	13.07	10.02	18.7
Cash Growth	77.41%	356.19%	-59.79%	30.45%	-46.44%	257.42%
Accounts Receivable	11.77	13.17	23.87	21.97	13.39	18.4
Other Receivables	0.07	0.14	0.16	0.41	1.02	0.43
Receivables	11.83	13.31	24.03	22.38	14.41	18.83
Inventory	31.3	39.82	36.72	22.85	21.35	14.67
Prepaid Expenses	11.86	3.1	4.19	12.38	2.06	4.71
Other Current Assets	-	0.38	2.3	2.3	1.28	1.67
Total Current Assets	69.97	80.57	72.5	72.97	49.11	58.57
Property, Plant & Equipment	0.46	0.69	0.78	0.9	1.22	0.8
Goodwill	10.22	10	10.28	10.28	10.69	10.65
Other Intangible Assets	64.78	71.6	64.14	70.37	76.57	76.36
Long-Term Deferred Tax Assets	9.56	8.98	8.04	6.81	-	-
Other Long-Term Assets	-	-	-	-	1.64	2.13
Total Assets	154.98	171.84	155.73	161.33	139.23	148.51
Accounts Payable	43.38	5.73	7.75	10.16	12.05	14.86
Accrued Expenses	-	35.29	35.48	23.26	17.13	12.47
Current Portion of Long-Term Debt	6.99	36.79	15.74	42.71	15.05	10.57
Current Portion of Leases	0.21	0.19	-	-	-	-
Current Income Taxes Payable	2.34	1.37	1.32	1.18	0.03	0.51
Other Current Liabilities	9.48	17.94	5.94	6.19	3.86	1.53
Total Current Liabilities	62.4	97.31	66.23	83.5	48.11	39.94
Long-Term Debt	18.08	-	33.61	26.78	39.03	34.09
Long-Term Leases	0.08	0.2	0.54	0.6	0.78	0.21
Long-Term Deferred Tax Liabilities	-	-	-	-	1.52	2.65
Other Long-Term Liabilities	22.22	22.19	25.03	28.01	31.99	53.61
Total Liabilities	102.77	119.7	125.41	138.88	121.43	130.5
Common Stock	96.22	96.1	76.39	69.01	68.69	66.69
Additional Paid-In Capital	11.55	12.01	12.01	11.31	10.38	9.5
Retained Earnings	-61.71	-62	-64.24	-64.03	-65.25	-62.37
Comprehensive Income & Other	6.15	6.03	6.17	6.16	3.97	4.2
Shareholders' Equity	52.21	52.14	30.32	22.45	17.79	18.02
Total Liabilities & Equity	154.98	171.84	155.73	161.33	139.23	148.51
Total Debt	25.35	37.18	49.9	70.08	54.86	44.87
Net Cash (Debt)	-10.38	-13.21	-44.64	-57.01	-44.84	-26.17
Net Cash Per Share	-0.33	-0.50	-2.00	-2.78	-2.26	-1.72
Filing Date Shares Outstanding	32.3	32.26	24.46	20.25	19.95	19.17
Total Common Shares Outstanding	32.31	32.26	24.46	20.18	19.95	19.17
Working Capital	7.57	-16.74	6.27	-10.53	1	18.63
Book Value Per Share	1.62	1.62	1.24	1.11	0.89	0.94
Tangible Book Value	-22.79	-29.46	-44.09	-58.21	-69.46	-69
Tangible Book Value Per Share	-0.71	-0.91	-1.80	-2.88	-3.48	-3.60
Machinery	-	1.26	1.12	1.07	1.06	0.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.